Barclays’s Chimerix, Inc. CMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-88,435
| Closed | -$753K | – | 5650 |
|
|
2025
Q1 | $753K | Buy |
88,435
+85,935
| +3,437% | +$474K | ﹤0.01% | 3277 |
|
|
2024
Q4 | $8.7K | Hold |
2,500
| – | – | ﹤0.01% | 5009 |
|
|
2024
Q3 | $2.33K | Hold |
2,500
| – | – | ﹤0.01% | 5074 |
|
|
2024
Q2 | $2.19K | Sell |
2,500
-324,856
| -99% | -$308K | ﹤0.01% | 4636 |
|
|
2024
Q1 | $347K | Sell |
327,356
-564,354
| -63% | -$587K | ﹤0.01% | 3810 |
|
|
2023
Q4 | $858K | Buy |
891,710
+57,166
| +7% | +$55.4K | ﹤0.01% | 3553 |
|
|
2023
Q3 | $801K | Hold |
834,544
| – | – | ﹤0.01% | 2492 |
|
|
2023
Q2 | $1.01M | Sell |
834,544
-42,689
| -5% | -$54.1K | ﹤0.01% | 2294 |
|
|
2023
Q1 | $1.11M | Buy |
877,233
+199,251
| +29% | +$325K | ﹤0.01% | 2658 |
|
|
2022
Q4 | $1.26M | Buy |
677,982
+251,128
| +59% | +$491K | ﹤0.01% | 2621 |
|
|
2022
Q3 | $825K | Buy |
426,854
+418,499
| +5,009% | +$939K | ﹤0.01% | 2364 |
|
|
2022
Q2 | $17K | Sell |
8,355
-3,838
| -31% | -$12.3K | ﹤0.01% | 4468 |
|
|
2022
Q1 | $56K | Sell |
12,193
-76,413
| -86% | -$426K | ﹤0.01% | 4073 |
|
|
2021
Q4 | $570K | Buy |
88,606
+58,325
| +193% | +$350K | ﹤0.01% | 3148 |
|
|
2021
Q3 | $188K | Buy |
30,281
+20,524
| +210% | +$141K | ﹤0.01% | 3650 |
|
|
2021
Q2 | $79K | Sell |
9,757
-40,168
| -80% | -$334K | ﹤0.01% | 3942 |
|
|
2021
Q1 | $480K | Buy |
49,925
+34,125
| +216% | +$313K | ﹤0.01% | 3201 |
|
|
2020
Q4 | $77K | Sell |
15,800
-6,364
| -29% | -$23.1K | ﹤0.01% | 4241 |
|
|
2020
Q3 | $55K | Sell |
22,164
-10,533
| -32% | -$31.1K | ﹤0.01% | 4554 |
|
|
2020
Q2 | $101K | Buy |
32,697
+16,745
| +105% | +$43.3K | ﹤0.01% | 4512 |
|
|
2020
Q1 | $23K | Sell |
15,952
-32,916
| -67% | -$57.6K | ﹤0.01% | 5604 |
|
|
2019
Q4 | $99K | Buy |
48,868
+24,474
| +100% | +$45.1K | ﹤0.01% | 5484 |
|
|
2019
Q3 | $58K | Sell |
24,394
-7,526
| -24% | -$21.7K | ﹤0.01% | 5838 |
|
|
2019
Q2 | $138K | Buy |
31,920
+17,563
| +122% | +$54K | ﹤0.01% | 5435 |
|
|
2019
Q1 | $30K | Buy |
14,357
+12,890
| +879% | +$29.4K | ﹤0.01% | 6179 |
|
|
2018
Q4 | $3K | Sell |
1,467
-27,637
| -95% | -$92.5K | ﹤0.01% | 6648 |
|
|
2018
Q3 | $112K | Buy |
29,104
+25,260
| +657% | +$108K | ﹤0.01% | 5449 |
|
|
2018
Q2 | $18K | Sell |
3,844
-6,653
| -63% | -$31.8K | ﹤0.01% | 6249 |
|
|
2018
Q1 | $55K | Buy |
10,497
+3,106
| +42% | +$15.7K | ﹤0.01% | 5841 |
|
|
2017
Q4 | $34K | Sell |
7,391
-54,190
| -88% | -$258K | ﹤0.01% | 5988 |
|
|
2017
Q3 | $324K | Sell |
61,581
-7,375
| -11% | -$36.3K | ﹤0.01% | 4004 |
|
|
2017
Q2 | $376K | Sell |
68,956
-83,219
| -55% | -$438K | ﹤0.01% | 3804 |
|
|
2017
Q1 | $971K | Buy |
152,175
+121,369
| +394% | +$688K | ﹤0.01% | 2767 |
|
|
2016
Q4 | $142K | Buy |
30,806
+29,974
| +3,603% | +$142K | ﹤0.01% | 4493 |
|
|
2016
Q3 | $4K | Sell |
832
-61,526
| -99% | -$282K | ﹤0.01% | 6089 |
|
|
2016
Q2 | $245K | Buy |
62,358
+29,361
| +89% | +$145K | ﹤0.01% | 3774 |
|
|
2016
Q1 | $165K | Sell |
32,997
-20,976
| -39% | -$137K | ﹤0.01% | 3982 |
|
|
2015
Q4 | $431K | Buy |
53,973
+41,714
| +340% | +$1.5M | ﹤0.01% | 3323 |
|
|
2015
Q3 | $466K | Buy |
12,259
+11,240
| +1,103% | +$555K | ﹤0.01% | 3402 |
|
|
2015
Q2 | $48K | Buy |
1,019
+111
| +12% | +$4.45K | ﹤0.01% | 5176 |
|
|
2015
Q1 | $33K | Sell |
908
-2,604
| -74% | -$103K | ﹤0.01% | 5567 |
|
|
2014
Q4 | $141K | Sell |
3,512
-216
| -6% | -$7.32K | ﹤0.01% | 4910 |
|
|
2014
Q3 | $101K | Sell |
3,728
-5,181
| -58% | -$126K | ﹤0.01% | 5321 |
|
|
2014
Q2 | $187K | Sell |
8,909
-4,979
| -36% | -$98.9K | ﹤0.01% | 4880 |
|
|
2014
Q1 | $305K | Buy |
13,888
+12,587
| +967% | +$254K | ﹤0.01% | 4387 |
|
|
2013
Q4 | $19K | Buy |
1,301
+983
| +309% | +$15.7K | ﹤0.01% | 6746 |
|
|
2013
Q3 | $7K | Sell |
318
-128
| -29% | -$2.63K | ﹤0.01% | 6907 |
|
|
2013
Q2 | $11K | Buy |
+446
| New | +$9.33K | ﹤0.01% | 7110 |
|
Other funds holding CMRX
Barclays's CMRX Position: Q2 2025 in Review
Barclays sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 88,435 shares — an estimated $753K sold.
Barclays first reported a position in CMRX in Q2 2013 and held it in 48 quarters. The position peaked at $1.26M in Q4 2022. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.
- Barclays reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
- Barclays sold 88,435 Chimerix, Inc. shares in Q2 2025, an estimated $753K.
- Barclays first reported a position in Chimerix, Inc. in Q2 2013 and held it in 48 quarters.
- Barclays's Chimerix, Inc. position peaked at $1.26M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.